General Information
Version
6.5
Revision date
2025-11-03
Product name
1-Bromopentane
CAS No.
110-53-2
Emergency telephone
+49 (0)696 43508409
Icons in SDS
Company Information
company name
Sigma-Aldrich Chemie GmbH
e-mail address of the competent person responsible for the Safety Data Sheet
technischerservice@merckgroup.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H226, H315, H411
Hazard statements
Code
Statements
H226
Flammable liquid and vapour
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Flammable liquids, (Category 3) H226: Flammable liquid and vapour. Skin irritation, (Category 2) H315: Causes skin irritation. Long-term (chronic) aquatic H411: Toxic to aquatic life with long lasting hazard, (Category 2) effects.
Signal word
Warning Warning
Hazard statements
H226 Flammable liquid and vapour. H315 Causes skin irritation. H411 Toxic to aquatic life with long lasting effects. none
Precautionary statements
P210 Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. P233 Keep container tightly closed. P240 Ground and bond container and receiving equipment. P241 Use explosion-proof electrical/ ventilating/ lighting equipment. P273 Avoid release to the environment. P303 + P361 + P353 IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water. none
Supplemental label elements
none Reduced Labelling (<= 125 ml) none
Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.